NCT03667040

Brief Summary

This study will examine a e-health resilience based program, JOOL, for chronic spine pain patients through the following aims: Aim 1: To test the effectiveness of a resilience based program known as JOOL Aim 2: To evaluate the characteristics of the participants most likely to benefit from this treatment

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 9, 2018

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

September 7, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 12, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2019

Completed
Last Updated

August 7, 2019

Status Verified

July 1, 2019

Enrollment Period

7 months

First QC Date

September 7, 2018

Last Update Submit

August 5, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • PROMIS (Patient Reported Outcomes Measurement Information System) Physical Function Scale- Short form 10

    10 item survey measuring physical function. Each question is measured on a scale of 1-5. The lowest score being 10 and highest score is 50. A higher score correlates with poor physical functioning.

    2 month

Study Arms (2)

Control Group

NO INTERVENTION

75 participants will take part in three visits (baseline, 30days and 60days)

Intervention

ACTIVE COMPARATOR

75 participants will take complete a baseline visit and then participate in the intervention. They will use the application, the JOOL app for 30 days. Then complete surveys at 30days and 60days after the interventions

Behavioral: JOOL app

Interventions

JOOL appBEHAVIORAL

Participants will use the JOOL app for 30 days

Intervention

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient of the UM Back \& Pain Center
  • Primary diagnosis of neck or back pain (spine pain)
  • Age 18-70
  • English speaking
  • Able to provide consent
  • Willing to download the mobile application and comply with study procedures
  • Antidepressant medications stable for ≥ 4 weeks
  • No plan to initiate a new non-pharmacological pain intervention during the 30-day study period (e.g. back surgery, physical therapy, behavioral therapy

You may not qualify if:

  • Having known psychotic disorder or the presence of another psychiatric condition (e.g. severe depression \[HADS scores ≥ 15\], suicidal ideation) or cognitive impairment (e.g. severe dyslexia, TBI) limiting ability to give consent and/or participate fully in the study
  • Currently undergoing psychotherapeutic care at the Back \& Pain Center because many of the concepts that are the focus of this study are already employed in that treatment
  • Other factors that at the discretion of the investigators would adversely affect study participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Back & Pain Center, University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Back PainNeck Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Afton Hassett, PsyD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 150 participants will be recruited; 75 participants into the intervention group and 75 into the control group. There will three visits, baseline and follow-up at 30 days and 60 days.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 7, 2018

First Posted

September 12, 2018

Study Start

August 9, 2018

Primary Completion

March 15, 2019

Study Completion

March 15, 2019

Last Updated

August 7, 2019

Record last verified: 2019-07

Locations